Remove Clinical Trials Remove Data Remove Legislation
article thumbnail

Survey: Three Of Four Military Veterans Would Consider Using Medical Cannabis

NORML

Seventy-five percent of military veterans say that they would consider using either “cannabis or cannabinoid products as a treatment option,” according to member survey data compiled by the group Iraq and Afghanistan Veterans of America (IAVA). The organization represents over 400,000 veterans nationwide.

article thumbnail

RYAH Medtech Inc. Completes Initial Shipment for Major UK-based Clinical Trial

Cannabis Law Report

The initial shipment is designated to be used by the Clinic in a pilot run in preparation for the previously announced study , based out of the United Kingdom, on the safety and efficacy of cannabis and hemp for the treatment of patients suffering from chronic pain. About RYAH Group, Inc. RYAH Group, Inc. Forward-Looking Statements.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

A Bipartisan Bill Is Pledging $75 Million for Psychedelic Research in Military PTSD Treatment

Veriheal

This article will delve into this historic legislation’s potential benefits and implications. The Grant Program Details The heart of this landmark legislation lies in the development of a robust grant program. ” The path to passing this legislation hasn’t been smooth despite the backing.

article thumbnail

Press Release: Mydecine Secures Financing and Provides Company Update on Clinical Trials, Drug Development and Technology Initiatives

Cannabis Law Report

The Financing will allow the Company to continue progressing its R&D, clinical trials and technology initiatives. “I I’m proud of our accomplishments to date and look forward to kicking off multiple clinical trials in early 2022,” said CEO, Josh Bartch. DENVER, Dec. Advancements in IP and Drug Development.

article thumbnail

Not-very-NICE: UK Cannabis Policy and Harm to Patients

CannaTech

Last week NICE released the first draft of their evidence-based guidelines, concluding it could not recommend CBMPs for routine use because of high cost and a dearth of clinical trial evidence. Furthermore, pharmaceutical companies often fund and initiate randomised clinical trials to validate their drugs.

article thumbnail

Psilocybin-Alcohol Study, FDA’s Psychedelic Guide, & the NCAA’s Cannabis Overhaul Begins

Veriheal

For their analysis, researchers conducted qualitative interviews with 13 individuals who had participated in a psilocybin clinical trial. The 13 individuals were chosen because of their reported improvements in negative drinking behavior following the clinical trial.

article thumbnail

These Patient Advocacy Groups Are Working Together to Expand the Scope of Cannabis Research

Veriheal

states pass relevant legislation and educating doctors about the power of cannabis medicine. Of course, legalization and education efforts can only go so far without data, and that’s where RoC’s research initiatives come into play. RoC also works to increase patients’ access to medical cannabis by helping U.S.